With $3.5B in fresh capital, Kleiner Perkins is going all in on AI

Kleiner Perkins raised $3.5B across two new funds—$1.0B for its 22nd early-stage fund and $2.5B for a late-stage growth vehicle—up from a $2.0B raise less than two years ago. The firm’s larger haul is underpinned by early stakes in fast-growing AI startups (Together AI, Harvey, OpenEvidence) and positions in Anthropic and SpaceX, plus realized returns from Figma’s IPO (it led Figma’s $25M Series B in 2018) and an acqui-hire exit for Windsurf. Kleiner now runs with a lean team of five partners and recent leadership moves include Ev Randle departing for Benchmark and Annie Case moving to an advisory role.

Analysis

Large, concentrated pools of late-stage capital change market microstructure: more dry powder chasing fewer high-quality growth rounds raises pre-money benchmarks, compresses future IRRs for new limited partners, and tilts startups toward valuation-insulating strategies (longer hold periods, secondary liquidity to insiders). That dynamic reduces near-term supply into public markets — when supply is scarce, successful IPOs (and their public comps) enjoy multiple expansion, but the bar for positive exits rises, amplifying dispersion across cohorts over the next 12–24 months.

A tiny GP team running outsized funds creates asymmetric key-person and operational risk; deal sourcing and syndicate economics will increasingly rely on follow-on checks and brand leverage rather than deep, seat-at-the-table diligence. Second-order effects: larger VCs will preferentially syndicate with established crossover funds and strategic corporate buyers, accelerating secondary-market privatizations and M&A activity for high-quality AI assets — favoring acquirers with strong balance sheets and low cash returns-to-shareholder pressure.

Catalysts to watch on 3–24 month horizons include headline IPOs (that reprice comps), large strategic acquisitions by hyperscalers, and any regulatory/legal actions around AI safety that could reprice late-stage cohorts downward. The primary reversal risk is a macro shock or a regulatory-led re-rating of AI monetization assumptions; either can turn current funding abundance into a near-term markdown event as valuations re-sync with revenue cadence.

Key Decisions for Investors

• FIG — Buy shares, 1–2% NAV, target +30–50% in 6–12 months with a hard stop at −25%. Rationale: scarcity-premium on proven public exits when late-stage supply tightens; downside protected by visible revenue and network effects. Take profits if FIG outperforms sector by >20% in 3 months.
• GOOGL/AMZN pair — Put on a 12–24 month market-neutral pair: go long GOOG (GOOGL) and short AMZN equal notional, 2% NAV gross each. Rationale: capture differential optionality for Google to monetize enterprise AI and M&A optionality versus Amazon’s lower-margin retail-aligned AI spend. Risk/reward: expect 1.5–2.0x upside on spread if Google leads AI monetization; unwind if spread moves >10% against position.
• GOOGL call spread — Buy an 18-month call spread on GOOG (e.g., buy modest ITM, sell higher strike) sized 1% NAV to express M&A/AI monetization upside with capped cost. Rationale: asymmetric payoff into potential Anthropic/other IPO/M&A windows while limiting premium decay. Stop-loss: close if implied volatility compresses >30% without fundamental progression toward announced AI product revenue milestones.